A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

2.5 billion under management

250 companies supported for 20 years

70 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their development models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

13.01.2021 - andera Life Sciences

MMI appoints healthcare industry veteran Mark Toland as CEO

12.01.2021 - andera MidCap - Press releases

Andera MidCap invests in Pusterla 1880

Combined Shape

07.01.2021 - andera Life Sciences - Press releases

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

Combined Shape

05.01.2021 - andera Life Sciences - Press releases

Andera Partners sells its Life Sciences’ portfolio company Arvelle Therapeutics

Combined Shape

04.01.2021 - andera Life Sciences - Press releases

Inotrem’s COVID-19 Phase IIa Clinical Trial declared “National Priority Research” by the French gove…

Combined Shape

21.12.2020 - Uncategorized - Press releases

Significant agreements with Chinese market leaders in our Life Sciences portfolio

Combined Shape

01.12.2020 - Andera Partners - Press releases

Andera Partners renames all its activities

Combined Shape

21.10.2020 - Andera Partners - Press releases

The Power of And

Combined Shape

12.10.2020 - andera Life Sciences - Press releases

Medlumics lands a 14M€ new financing round

Combined Shape

28.08.2020 - andera Life Sciences - Press releases

Reviral raises $44 million in Series C financing

Combined Shape

06.08.2020 - andera Life Sciences - Press releases

T-knife completes €66m Series A financing

Combined Shape

23.07.2020 - andera Life Sciences - Press reviews

COVID-19: assessing nangibotide in mechanically ventilated patients with COVID-19

Combined Shape

29.06.2020 - andera Acto - Press releases

ActoMezz IV: a single closing at more than €500 million

Combined Shape

11.06.2020 - andera Life Sciences - Press releases

BioDiscovery sells Corvidia to Novo Nordisk

Combined Shape

06.05.2020 - andera Life Sciences - Press releases

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

Combined Shape
Our Latest News